ATI-7505

DRUG2 trials

Sponsors

Procter and Gamble, Mayo Clinic

Conditions

Chronic ConstipationHealthy

Phase 1

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

CompletedNCT01094821

Mayo ClinicHealthy

Start: 2005-01-31End: 2005-12-31Updated: 2010-03-29

Phase 2

Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

TerminatedNCT00501241

Procter and GambleChronic Constipation

Start: 2007-07-31End: 2008-07-31Target: 214Updated: 2009-06-17